Sastasundarventures earnings calls.

Sastasundar Ventures delivered a strong Q3 FY26 with revenue of ₹341 crore (+22% YoY)Current reported value: revenue of ₹341 crore (+22% YoY). No comparable prior figure is available in the source record. and a sharp operating turnaround to EBIT positive ₹1 croreCurrent reported value: EBIT positive ₹1 crore. No comparable prior figure is available in the source record. from a loss of ₹37 crore in Q3 FY25. The company cited resumed growth momentum after automation-related disruptions in prior quarters, with B2B (Retailer Shaki) and B2C (Sastasundar) both showing traction. Gross margins expanded 160bps YoY to 7.6%Current reported value: 160bps YoY to 7.6%. No comparable prior figure is available in the source record. driven by improved product mix. Management reaffirmed its capital-efficient model with only ₹83 crore deployed in IP-driven businessesCurrent reported value: ₹83 crore deployed in IP-driven businesses. No comparable prior figure is available in the source record., and targets EBITDA breakeven for Retail by Q4 FY26Current reported value: EBITDA breakeven for Retail by Q4 FY26. No comparable prior figure is available in the source record. and contribution margin breakeven for B2C in FY27Current reported value: contribution margin breakeven for B2C in FY27. No comparable prior figure is available in the source record.. The JTO generic brand launched leveraging the existing 65,000 retailer network, targeting 2-3% revenue contribution next year with 30% gross marginsCurrent 30% gross margins. Reported change: vs 7.6% core business.. Warehouse expansion (80,000 sq ft in West Bengal, 1 lakh sq ft in Noida) and AI investments (₹25 crore annual budget) underpin the growth roadmap. Key risks include GST working capital drag, slower-than-expected B2C scaling, and potential channel conflict with pharma companies on the JTO brand.